ArticleTranslational vision science & technology2026
Increased Erythrocyte Osmotic Fragility as a Risk Factor for Predicting Glaucoma.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: A significant portion of patients with glaucoma exhibit normal intraocular pressure (IOP), suggesting additional risk factors other than elevated IOPs that are critical for the pathogenesis of glaucoma. This study aimed to identify blood biomarkers associated with glaucoma and construct a predictive model for glaucoma. Methods: Peripheral blood samples from patients with glaucoma and 175 age- and sex-matched healthy controls were analyzed using an automated hematology analyzer. Red blood cell membrane stability was analyzed by an osmotic fragility test. Red blood cell morphologies were analyzed using Giemsa staining. A least absolute shrinkage and selection operator (LASSO) regression model was constructed to predict glaucoma. Results: LASSO regression analysis of blood biomarkers identified important biomarkers for distinguishing patients with glaucoma from healthy controls, which also implied that red blood cells from patients with glaucoma were more prone to rupture. The erythrocyte osmotic fragility (EOF) test revealed significantly higher erythrocyte fragility in patients with glaucoma compared with healthy controls (P < 0.001). To improve the prediction accuracy, a new LASSO regression model for glaucoma prediction was constructed by integrating EOF. The probability of glaucoma (p) was calculated. The revised predictive model achieved an accuracy of 88.68% with a sensitivity of 92.59% and specificity of 84.62%. Validation using an independent dataset demonstrated the great predictive performance of the predictive model, with an area under the ROC (receiver operating characteristic) curve (AUC) value of 0.97. Conclusions: Increased EOF is a risk factor for glaucoma. EOF, along with several blood biomarkers, helps diagnose glaucoma. Translational Relevance: Measurement of EOF could facilitate clinical glaucoma diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.